Status:
COMPLETED
Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Scleroderma Foundation
Conditions:
Systemic Sclerosis
SSc
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test two rehabilitation programs to improve arm function for patients with scleroderma. This is a Phase 2 randomized controlled trial in which participants will be asse...
Detailed Description
The specific aims of this study are to: 1. Determine the short and longer-term effects of an intensive (8-week in-person occupational therapy treatment with prescribed home exercises) on improving ar...
Eligibility Criteria
Inclusion
- Have a diagnosis of systemic sclerosis including:
- Diffuse cutaneous subset
- Disease duration \< 5 years from 1st non Raynaud phenomenon sign or symptom
- Have a contracture of the hand and other joint in at least one arm, such as wrist, elbow, or shoulder, with the ability to demonstrate active range of motion in that arm
- Willing to travel to participate in therapy and outcome assessments.
- Have an Android, iPhone, iPad or computer tablet to load the home exercise App.
- English speaking
Exclusion
- issues that preclude meaningful participation in study procedures (e.g. concurrent or complex medical issues, inability to use home exercise app, etc.)
Key Trial Info
Start Date :
April 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 26 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03482219
Start Date
April 16 2018
End Date
September 26 2020
Last Update
September 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109